MY151332A - Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia - Google Patents
Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemiaInfo
- Publication number
- MY151332A MY151332A MYPI20070215A MY151332A MY 151332 A MY151332 A MY 151332A MY PI20070215 A MYPI20070215 A MY PI20070215A MY 151332 A MY151332 A MY 151332A
- Authority
- MY
- Malaysia
- Prior art keywords
- tpo peptide
- pharmaceutical compositions
- anemia
- treatment
- peptide compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 208000007502 anemia Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A METHOD OF TREATING ANEMIA ID DISCLOSED. THE METHOD INCLUDES ADMINISTERING A TPO PEPTIDE COMPOUND TO A SUBJECT. PHARMACEUTICAL COMPOSITIONS INCLUDING A TPO PEPTIDE COMPOUND AND A PHARMACEUTICALLY ACCEPTABLE CARRIER AS WELL AS DIAGNOSTIC METHODS EMPLOYING A LABELED TPO PEPTIDE COMPOUND ARE ALSO DISCLOSED.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/354,065 US7615533B2 (en) | 2004-08-16 | 2006-02-14 | TPO peptide compounds for treatment of anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY151332A true MY151332A (en) | 2014-05-15 |
Family
ID=38813270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20070215 MY151332A (en) | 2006-02-14 | 2007-02-13 | Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR059573A1 (en) |
| DO (1) | DOP2007000031A (en) |
| MY (1) | MY151332A (en) |
| PE (1) | PE20080268A1 (en) |
| TW (1) | TWI458488B (en) |
| UY (1) | UY30151A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA82710C2 (en) * | 2003-08-28 | 2008-05-12 | Орто-Макнейл Фармацевтикал, Инк. | Peptide that binds the thrombopoietin receptor (variants) and method for treatment of thrombocytopenia (variants) |
-
2007
- 2007-02-13 MY MYPI20070215 patent/MY151332A/en unknown
- 2007-02-13 TW TW096105153A patent/TWI458488B/en not_active IP Right Cessation
- 2007-02-13 AR ARP070100593 patent/AR059573A1/en unknown
- 2007-02-14 PE PE2007000162A patent/PE20080268A1/en not_active Application Discontinuation
- 2007-02-14 DO DO2007000031A patent/DOP2007000031A/en unknown
- 2007-02-14 UY UY30151A patent/UY30151A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR059573A1 (en) | 2008-04-16 |
| PE20080268A1 (en) | 2008-04-28 |
| TWI458488B (en) | 2014-11-01 |
| UY30151A1 (en) | 2007-07-31 |
| TW200808341A (en) | 2008-02-16 |
| DOP2007000031A (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009006742A (en) | Novel compounds. | |
| WO2008124085A3 (en) | Methods of using combinations of mek and jak-2 inhibitors | |
| GB2430935A (en) | Tetrapeptide analogs | |
| MX2009012558A (en) | Drug combinations for the treatment of duchenne muscular dystrophy. | |
| MX2010002392A (en) | Improved brimonidine compositions for treating erythema. | |
| ZA200810113B (en) | Method for the treatment and prevention of ocular disorders | |
| WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
| WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
| WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
| TW200806299A (en) | Treatment of pain | |
| CY1115629T1 (en) | USE OF TROP Peptide Compounds and Pharmaceutical Compositions in Anemia Therapy | |
| TNSN07419A1 (en) | Methods for treating drug resistant cancer | |
| UA93709C2 (en) | 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions | |
| MX2009009574A (en) | Treatment of melanoma. | |
| MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
| WO2009019708A3 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200639159A (en) | Treatment of pain | |
| MXPA05010020A (en) | Oxamide derivatives useful as raf-kinase inhibitors. | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| WO2008051527A3 (en) | Sustained release of agents for localized pain management | |
| UA104281C2 (en) | Antitumoral peptide analogs, process for the preparation thereof and pharmaceutical composition based thereon | |
| SE0501903L (en) | Boron compounds useful at BNCT | |
| PT2234966E (en) | Azetidine derivatives, their preparation and their application in therapy |